Chemoinformaics analysis of 2-METHYLBENZOFURAN
| Molecular Weight | 132.162 | nRot | 0 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 10 |
| Exact Molecular Weight | 132.058 | nRing | 2 |
| Solubility: LogS | -3.35 | nHRing | 1 |
| Solubility: LogP | 3.092 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
| nHA | 1 | APOL | 21.1663 |
| nHD | 0 | BPOL | 9.76166 |
| QED | 0.537 |
| Synth | 1.721 |
| Natural Product Likeliness | 0.05 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.788 |
| HIA | 0.003 |
| CACO-2 | -4.461 |
| MDCK | 0.0000182 |
| BBB | 0.363 |
| PPB | 0.921892 |
| VDSS | 1.23 |
| FU | 0.0883992 |
| CYP1A2-inh | 0.987 |
| CYP1A2-sub | 0.936 |
| CYP2c19-inh | 0.867 |
| CYP2c19-sub | 0.713 |
| CYP2c9-inh | 0.133 |
| CYP2c9-sub | 0.763 |
| CYP2d6-inh | 0.128 |
| CYP2d6-sub | 0.891 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.438 |
| CL | 10.315 |
| T12 | 0.598 |
| hERG | 0.03 |
| Ames | 0.508 |
| ROA | 0.195 |
| SkinSen | 0.197 |
| Carcinogencity | 0.865 |
| EI | 0.992 |
| Respiratory | 0.035 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.849133 |